Singapore Biotech Firm Mulls Brunei Plant
By Finaz Daniel

Bandar Seri Begawan - A delegation from Transcu Ltd, a Singapore-based biotechnology company, is exploring the possibility of partnering with local investors in setting up a manufacturing plant and distribution hub here.

At the invitation of the Brunei Economic Development Board (BEDB), the delegation, led by its Chief Executive Officer Akihiko Matsumura, gave a presentation yesterday at iCentre on the firm's development of a system for noninvasive delivery of medicine into the human body.

Transcu Ltd has already engaged pharmaceuticals in the US and Europe and expresses hopes of breaking into the Islamic market.

BEDB Acting Chairman Dato Paduka Timothy Ong said, "The BEDB is aggressively seeking to attract high value-added investments to Brunei in line with our mission to create new opportunities for our people.

"Brunei is the ideal platform for exporting to the Muslim world," he said.

Toshimichi Ohyama, director and executive director of business operations at Transcu, said Transcu's system enables the delivery of therapeutic drugs into the human body without the use of needles, effectively eradicating the pain factor.

The system is customised to efficiently deliver drugs for a wide variety of medical and cosmetic applications, thus, replacing existing conventional methods such as injections, oral administrations and patches.

With three granted patents and 288 filed patents in hand, the company has filed for another 32 new patent applications this year.

Matsumura said the company will be meeting with key personnel and local stakeholders.

The Transcu delegation will be leaving the sultanate today. -- Courtesy of The Brunei Times

Click Here To Have Your Say On This Story

Brudirect.com News

Brunei's Fastest Growing Website with